Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren in Hypertensive Patients With Stable Heart Failure
NCT00219011Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2005
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of aliskiren in heart failure (HF), sponsored by Novartis. Started May 2005; status: completed.
02
Drugs
aliskiren
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00219011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00219011.